Re: Merrill Lynch Picks Diabetes Drug Makers as Real Winners (MRK, BMY, LLY, NOV, MN

Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Reply New Message

Prev Message Back To Forum Threaded View Next Message

swingtrader88

Rank: Vice President [?]

Points: 1424 [?]

Votes: 10 Score: 4.2 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Merrill Lynch Picks Diabetes Drug Makers as Real Winners (MRK, BMY, LLY, NOV, MN

in response to

Re: Merrill Lynch Picks Diabetes Drug Makers as Real Winners (MRK, BMY, LLY, NOV, MN

liahall

posted on Mar 27, 2013 04:05PM

Lia,

I will go on record if Afrezza has a 4% market share 12 months after approval the stock will be selling for $30-40/ share even accounting for additional dilution. One would assume that just about every large pharmceutical company would hand over billions to acquire 4% of an already huge and growing market in the US in one year.